our guest host is anne mulcahy.s. >> target, johnson & johnson, "washington post" company. >> yes. >> another lousy j&j news yesterday, the risperdal thing? >> it's on appeal. it's a jury. most think it won't stick. >> looking at the headlines now. they also say first quarter net 4.25 billion and -- >> 21.64 versus estimates of 25.50. >> they're beating across the way. >> anything on reverves? >> no, i have the bazle number. >> i can give you the nonpore terming assets, 26.6 versus 26 a year ago. both went up a little bit for nonperformers but you would think that it's still headed that way but probably not at the pace that is used to be. quarterly net chargeoff, 2.4 billion. that is a decline at wells fargo of 245 million. >> and reserve release of $400 million pretax improved portfolio. >> so they're reserving a lot less. >> and they're continuing reserve releases given there's no significant deterioration in the economy. future reserve releases are seen in 2012, absent deterioration. >> the chairman and ceo says